Reuters logo
BRIEF-Akebia Therapeutics reports Q3 loss per share $0.49
November 8, 2017 / 9:31 PM / a month ago

BRIEF-Akebia Therapeutics reports Q3 loss per share $0.49

Nov 8 (Reuters) - Akebia Therapeutics Inc

* Akebia Therapeutics announces third quarter 2017 financial results

* Q3 loss per share $0.49

* Q3 earnings per share view $-0.51 -- Thomson Reuters I/B/E/S

* Akebia Therapeutics Inc -cash, cash equivalents and available for sale securities $329.7 million at sept 30 versus $260.3 million as at dec 31, 2016​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below